LeMaitre Q2 2021 sales $40.7M (+64% YoY), EPS $0.40; declares $0.11 dividend; FY21 guidance raised

LEMAITRE VASCULAR INC

2021-Q2 EPS reported $0.68 revenue$76,553,000

Sales $40.7M (+64% or +35% organic); operating income $11.1M (+128%); net income $8.3M (+137%); diluted EPS $0.40 (+131%).
Gross margin 65.8% vs 68.5% in Q2 2020; decline driven by product mix, manufacturing inefficiencies, and inventory write-downs.
Quarterly dividend of $0.11/share approved, payable Sept 9, 2021 to record holders on Aug 26, 2021.
FY 2021 guidance: sales $154.1M–$158.1M (+21% YoY at midpoint), EPS $1.30–$1.40 (+30% at midpoint).
Completed $54.5M follow-on stock offering on July 16; $23.0M net proceeds used to repay long-term debt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.